Publications & Works

Publication Network
Articles 42
All (42)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (12)
Scopus (39)
TRDizin (16)

1. Demographical and Clinical Characteristics, Risk Factors, and Prognosis of Adult Patients with Herpes Zoster in Türkiye: A Retrospective, Multi-Center Study (VARICOMP-Adult Study)

ŞENOL E., AZAP A., Sayin Kutlu S., Kutlu M., ERBAY A., KOÇYİĞİT P., et al.
Infectious Disease Reports , vol.17, no.3, 2025 (ESCI, Scopus)

2. Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases.

Bağrıaçık E. Ü., Karakus R., Yaman M., Oruklu N., Araz M., Kalayci Z., et al.
PloS one , vol.20, no.5, 2025 (SCI-Expanded, Scopus)

3. Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye

GÜZEL TUNÇCAN Ö., Çağirgan S., Özdoğu H., Civriz Bozdağ S., Vural F., Pehlivan M., et al.
Turkish Journal of Medical Sciences , vol.55, no.1, pp.52-64, 2025 (SCI-Expanded, Scopus, TRDizin)

4. The Prognostic Value of Extended Inflammation Parameters and Soluble Fibrin Monomer Complex in Covid-19 Patients in The Intensive Care Unit

Gaygısız Ü., Kaya Z., Kirkiz Kayalı S., Özger H. S., Aydoğdu M., Güzel Tunçcan Ö., et al.
Journal of Clinical and Laboratory Research , vol.7, no.3, pp.1-7, 2024 (Peer-Reviewed Journal) Creative Commons License

5. ENG: comparative evaluation of side effects and the factors affecting vaccıne preferences of healthcare workers within the booster Covid-19 vaccınation in turkey

YILDIZ Y., MAVİ H. M., Sultanova F., BÜYÜKKÖRÜK M., ÖZGER H. S., ŞENOL E.
Turkish Journal of Clinics and Laboratory , vol.14, 2023 (TRDizin)

6. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review

Badur S., ŞENOL E., AZAP A., Yesiloglu C., Ozakay A., Ozturk S., et al.
Infectious Diseases and Therapy , vol.12, no.8, pp.1937-1954, 2023 (SCI-Expanded, Scopus) Creative Commons License

7. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment

BİR YÜCEL K., SÜTCÜOĞLU O., YAZICI O., YILDIZ Y., ŞENOL E., ÜNER A.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.3, pp.760-763, 2023 (SCI-Expanded, Scopus)

8. Use of infection biomarkers in the emergency department

ÖZGER H. S., ŞENOL E.
Turkish Journal of Emergency Medicine , vol.22, no.4, pp.169-176, 2022 (Scopus, TRDizin)

9. Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study

YILDIZ Y., ÖZGER H. S., ŞENOL E., KARAKUŞ R., BÜYÜKKÖRÜK M., ALTIN F. B., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.122, pp.99-106, 2022 (SCI-Expanded, Scopus) Sustainable Development

10. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress

KÜÇÜKKARAPINAR M., Yay-Pence A., YILDIZ Y., BÜYÜKKÖRÜK M., YAZ AYDIN G., Deveci-Bulut T. S., et al.
JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, pp.1077-1089, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

11. p Epidemiology and Risk Factors of Candidemia Among Hospitalized Patients in a Turkish Tertiary Care Hospital

Mirza A., ŞENOL E., KALKANCI A.
CLINICAL LABORATORY , vol.68, no.1, pp.196-206, 2022 (SCI-Expanded, Scopus)

12. Parotitis and Orchitis Cases due to Measles-Mumps-Rubella Vaccine Kızamık-Kabakulak-Kızamıkçık Aşı Uygulaması Sonrası Gelişen Parotit ve Orşit Olguları

Sultanova F., ÖZGER H. S., Özer F., Tonguz H. Ş., YILDIZ Y., ŞENOL E.
Klimik Dergisi , vol.35, no.1, pp.46-48, 2022 (ESCI, Scopus, TRDizin) Sustainable Development

13. Epidemiology and Risk Factors of Candidemia Among Hospitalized Patients in a Turkish Tertiary Care Hospital

Mirza A., ŞENOL E., KALKANCI A.
CLINICAL LABORATORY , vol.68, pp.196-206, 2022 (SCI-Expanded, Scopus) Sustainable Development

14. Ceftazidime - Avibactam susceptibility among carbapenem-resistant Enterobacterales in a pilot study in Turkey

ÖZGER H. S., EVREN E., Yildiz S. S., Erol C., Bayrakdar F., AZAP Ö., et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA , vol.68, no.4, pp.256-261, 2021 (SCI-Expanded, Scopus)

15. Serial measurement of cytokines strongly predict COVID-19 outcome

Ozger H. S., Karakus R., Kuscu E. N., Bagriacik U. E., Oruklu N., Yaman M., et al.
PLOS ONE , vol.16, no.12, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

16. Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID-19): A multicentre experience

Yılmaz Demirci N., Uğraş Dikmen A., Tasci C., Dogan D., Arslan Y., Ocal N., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.9, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

17. The Role of Pneumococcal Pneumonia among CommunityAcquired Pneumonia in Adult Turkish Population: TurkCAP Study

ŞENOL E., ÇİLLİ A., Gunen H., Sener A., Dumlu R., Odemis A., et al.
TURKISH THORACIC JOURNAL , vol.22, no.4, pp.339-345, 2021 (ESCI, Scopus, TRDizin)

18. Comparison of the clinical and radiological features of COVID-19 and other viral pneumonias

Özger H. S., Aysert-Yildiz P., Gaygisiz Ü., Tekin-Taş Z., Avşar F. Z., Şenol E., et al.
Gazi Medical Journal , vol.32, no.2, pp.213-218, 2021 (ESCI, Scopus) Sustainable Development

19. Evaluation of the Frequency of Side Effects after Coronovirus Inactive Vero Cell Vaccine in Healthcare Workers of Gazi University Hospital

YILDIZ Y., SULTANOVA F., YILDIZ M., EKER H. M., ÖZGER H. S., Ozer F., et al.
GAZI MEDICAL JOURNAL , vol.32, no.4A, pp.651-654, 2021 (ESCI, Scopus) Sustainable Development

20. Comparison of the Clinical and Radiological Features of COVID-19 and Other Viral Pneumonias

ÖZGER H. S., AYSERT YILDIZ P., GAYGUSUZ Ü., TEKİN TAŞ Z., AVŞAR F. Z., ŞENOL E., et al.
GAZI MEDICAL JOURNAL , vol.32, no.2, pp.213-218, 2021 (ESCI, Scopus) Sustainable Development

21. Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant P. aeruginosa

Albayrak A., FAKIOĞLU D. M., ŞENOL E.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE , vol.27, no.2, pp.121-122, 2020 (SCI-Expanded, Scopus)

22. Vaccination of adults with heart failure and chronic heart conditions: Expert opinion

ÇELİK A., Altay H., Azap A., ÇAVUŞOĞLU Y., NALBANTGİL S., ŞENOL E., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.46, no.8, pp.723-734, 2018 (ESCI, Scopus, TRDizin) Sustainable Development

23. Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey

Neoh C. F., ŞENOL E., KARA A., DİNLEYİCİ E. Ç., Turner S. J., Kong D. C. M.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.37, no.9, pp.1777-1784, 2018 (SCI-Expanded, Scopus)

24. The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey

Aki S. Z., Sucak G. T., GÜZEL TUNÇCAN Ö., KÖKTÜRK N., ŞENOL E.
TRANSPLANT INFECTIOUS DISEASE , vol.20, no.4, 2018 (SCI-Expanded, Scopus) Sustainable Development

25. Pneumococcal Vaccine as One of the Immunization Coverage Targets for Adulthood Vaccines: A Consensus Report of the Study Group for Adult Immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases

ŞENOL E., Azap A., Erbay A., Alp-Cavus S., KARAKUŞ R., Acar A.
KLIMIK JOURNAL , vol.31, no.1, pp.2-18, 2018 (ESCI, Scopus, TRDizin) Sustainable Development

26. Erişkin Bağışıklamasının Hedefindeki Aşılardan Biri Olarak Pnömokok Aşısı: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Erişkin Bağışıklaması Çalışma Grubu Uzlaşı Raporu

Şenol E., Azap A., Erbay A., Alp Çavuş S., Karakuş R., Acar A.
KLIMIK DERGISI , vol.31, no.1, pp.2-18, 2018 (Scopus, TRDizin) Sustainable Development

27. Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey

Neoh C. F., ŞENOL E., KARA A., DİNLEYİCİ E. Ç., Turner S. J., Kong D. C. M.
MYCOSES , vol.60, no.11, pp.714-722, 2017 (SCI-Expanded, Scopus)

28. The pilgrimage and the burden of pneumococcal disease in adults

Koksal I., ŞENOL E., ÇİLLİ A., Alici D. E.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.65, no.4, pp.327-332, 2017 (ESCI, Scopus, TRDizin) Sustainable Development

29. Yoğun Bakım Ünitelerinde Kandida Skoru nun Kandidemi İnsidansındaki Azalmaya olanEtkisi

DİZBAY M., GÜZEL TUNÇCAN Ö., BARAN AKSAKAL F. N., HIZEL K., ARMAN G. D., ŞENOL E., et al.
Gazi Medical Journal , 2016 (Scopus, TRDizin)

30. Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines

Revanli R. A., Yuceer C., ŞENOL E., Azap A., Erbay A., Alp-Cavus S., et al.
KLIMIK JOURNAL , vol.29, no.1, pp.15-20, 2016 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development

31. Awareness and attitude of family physicians about human papilloma virus and herpes zoster vaccines(Article)[Aile hekimlerinin İnsan papilloma virusu ve zona aşıları hakkındaki bilgi düzeyleri ve tutumlarının araştırılması]

Revanlı R., Yüceer C., Şenol E., Azap A., Erbay A., Alp Çavuş S., et al.
KLIMIK DERGISI , vol.29, no.1, pp.15-20, 2016 (Scopus, TRDizin) Sustainable Development

32. Decrease in the Incidence of Candidemia with the Implementation of "Candida Score" in the Intensive Care Units

DİZBAY M., GÜZEL TUNÇCAN Ö., Aksakal N., HIZEL K., Arman D., ŞENOL E., et al.
GAZI MEDICAL JOURNAL , vol.27, no.3, pp.142-144, 2016 (ESCI, Scopus, TRDizin) Creative Commons License

33. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)

Boga C., Bolaman Z., Cagirgan S., Karadogan I., ÖZCAN M. A., ÖZKALEMKAŞ F., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.2, pp.100-117, 2015 (SCI-Expanded, Scopus, TRDizin)

34. Isolated Severe Immune Thrombocytopenia due to Acute Brucellosis

GÜZEL TUNÇCAN Ö., DİZBAY M., ŞENOL E., Aki Z., Ozdemir K.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.30, 2014 (SCI-Expanded, Scopus) Creative Commons License

35. Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections

Pamukcuoglu M., Emmez H., GÜZEL TUNÇCAN Ö., ÖNER A. Y., Cirak M. Y., ŞENOL E., et al.
HEMATOLOGY , vol.19, no.3, pp.158-162, 2014 (SCI-Expanded, Scopus)

36. Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey

Turner S. J., ŞENOL E., KARA A., Al-Badriyeh D., DİNLEYİCİ E. Ç., Kong D. C. M.
BMC INFECTIOUS DISEASES , vol.13, 2013 (SCI-Expanded, Scopus)

37. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation

GÜZEL TUNÇCAN Ö., Aki S. Z., AKYÜREK N., Sucak G., ŞENOL E.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.5, no.5, pp.406-409, 2011 (SCI-Expanded, Scopus) Creative Commons License

38. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates

GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., ERBAŞ G., Aki S. Z., ŞENOL E., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.14, 2010 (SCI-Expanded, Scopus) Creative Commons License

39. Five Years Surveillance of Nosocomial Stenotrophomonas maltophilia Infections in Gazi University Hospital

DİZBAY M., Tunccan Ö., Maral I., Aktas F., ŞENOL E.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.6, pp.1406-1411, 2009 (SCI-Expanded, Scopus)

40. Nötropenik Hasta Grubunda Mantar Enfeksiyonlarının Tanısında Moleküler Yöntemlerin Desteklediği Bir Laboratuar Akış Şeması Oluşturulması

KALKANCI A., HAZNEDAR R., GÜZEL TUNÇCAN Ö., ŞENOL E., KÖKTÜRK N.
Moleküler Tanı Dergisi , 2007 (TRDizin)

41. Could Candida dubliniensis be involved in lung fungal balls?

KALKANCI A., KÖKTÜRK N., ŞENOL E., ACAR K., Guzel O., SANCAK B., et al.
Revista Iberoamericana de Micologia , vol.22, no.3, pp.157-159, 2005 (SCI-Expanded, Scopus)

42. Hepatit A ve Epstein-Barr Virüs Koinfeksiyonu

HIZEL K., ALTUNÇEKİÇ YILDIRIM A., GÜZEL TUNÇCAN Ö., ARMAN G. D., ŞENOL E., ULUTAN F., et al.
VİRAL HEPATİT DERGİSİ , vol.8, no.3, pp.178-180, 2003 (ESCI, TRDizin) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 14

1. Multipleks polimeraz zincir reaksiyonu (PCR) testinin cinsel yolla bulaşan enfeksiyonların yönetimine etkisi

ÖZGEN TOP Ö., ÖZGER H. S., AYSERT YILDIZ P., GÜÇLÜ F., Şahin F. Z., ŞAHİN E. A., et al.
XXIV. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi (KLİMİK 2024), Antalya, Turkey, 06 March 2024, (Summary Text) Creative Commons License

2. Yoğun bakım gerektiren COVID-19 enfeksiyonu olan hastalarda genişletilmiş enflamasyon parametrelerinin ve çözünür fibrin monomer komplekslerinin prognostik rolü

GAYGISIZ Ü., KAYA Z., KİRKİZ KAYALI S., ÖZGER H. S., AYDOĞDU M., GÜZEL TUNÇCAN Ö., et al.
Türk Yoğun Bakım Derneği (TYBD) 22. Ulusal Yoğun Bakım Kongresi 22-25 Şubat 2024 Antalya, Antalya, Turkey, 22 February 2024, (Summary Text)

3. The role of interferon alpha autoantibodies in the progress of COVID-19.

Erol Ç., Karakuş R., Özger H. S., Yaman M., Örüklü N., Yıldız Y., et al.
33rd European Congress of Clinical Microbiology & Infectious Diseases, Kobenhavn, Denmark, 15 - 18 April 2023, (Summary Text)

4. Hematolojik Malignite ve Kök Hücre Nakil Alıcılarında İnvaziv Fungal Enfeksiyon Spektrumu ve Antifungal Kullanım Pratikleri

YILDIZ Y., ŞENOL E.
37. ANKEM Akılcı Antibiyotik Kullanımı Kongresi, Turkey, 26 October 2022, pp.56-59, (Full Text)

5. Evaluation of Antibody Kinetics in Healthcare Workers (HCWs) of an Istutition in Turkey, Vaccinated With Inactivated COVID-19 Vaccine

YILDIZ Y., ÖZGER H. S., ŞENOL E., KARAKUŞ R., BÜYÜKKÖRÜK M., Altın F., et al.
32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), Barcelona, Spain, 23 April 2022, (Full Text)

6. Evaluation of antibody kinetics in healthcare workers (HCWs) of an instutition in Turkey, vaccinated with inactivated COVID-19 vaccine

Yıldız Y., Özger H. S., Şenol E., Karakuş R., Büyükkörük M., Altın F. B., et al.
32nd ECCMID, Lisbon, Portugal, 23 - 26 April 2022, (Full Text) Creative Commons License Sustainable Development

7. COVID-19 pandemisinin erişkin pnömokok aşılamasına ve toplumun aşı duyarlılığına etkisi

ŞEN F., YILDIZ Y., ÖZGER H. S., GÜZEL TUNÇCAN Ö., DİZBAY M., ŞENOL E.
Uluslararası İnfeksiyon dünyası Çalıştayı 2022, Ankara, Turkey, 23 March 2022, (Full Text) Sustainable Development

8. Sitokinlerin Seri Ölçümleri COVID-19 Sonucunu Güçlü Bir Şekilde Öngörür

Kuşcu N. E., Özger H. S., Karakuş R., Bağrıaçık E. Ü., Örüklü N., Yaman M., et al.
KLİMİK 2022, Antalya, Turkey, 09 March 2022, (Full Text) Creative Commons License Sustainable Development

9. Covid-19 Aşısını Takiben Gelişen Akut Abdusens Sinir Palsisi: Olgu Sunumu

KARAHÜSEYİNOĞLU E., BATUR ÇAĞLAYAN H. Z., ERKOÇ ATAOĞLU N. E., ŞENOL E., NAZLIEL B.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November 2021, (Summary Text)

10. Serum cytokine levels predicting mortality in COVID-19 patients.

ÖZGER H. S., KARAKUŞ R., KUŞCU N. E., BAĞRIAÇIK E. Ü., ÖRÜKLÜ N., YAMAN M., et al.
31st European Congress of Clinical Microbiology & Infectious Diseases, Viyana, Austria, 9 - 12 July 2021, (Summary Text)

11. Aile Hekimlerinin Zona ve HPV aşıları hakkındaki bilgi ve tutumlarının ölçülmesi

AZAP A., ŞENOL E., ERBAY A., ALP ÇAVUŞ S., KARAKUŞ R., Revanlı R. A., et al.
XVII. Türk Klİnİk Mİkrobİyolojİ ve İnfeksİyon HastalIklarI Kongresİ (Klİmİk 2015), Turkey, 25 - 29 March 2015, (Summary Text)

12. The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Hematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey

Aki S. Z., Sucak G. T., GÜZEL TUNÇCAN Ö., KÖKTÜRK N., ŞENOL E.
BMT Tandem Meetings, California, United States Of America, 11 - 15 February 2015, vol.21, (Summary Text) Creative Commons License Sustainable Development

13. PROPHYLACTIC ANTIFUNGAL TREATMENT IN HEMATOLOGIC MALIGNANCIES

ŞENOL E.
5th International Eurasian Hematology Congress, Antalya, Turkey, 15 - 19 October 2014, vol.38, (Summary Text)

14. Diş hekimliğinde AIDS hepatit ve diğer enfeksiyon riskleri

DOĞAN A., KARACA İ. R., ŞENOL E.
Gazi üniversitesi diş hekimliği fakültesi 2. uluslararası bilimsel kongresi, 4 - 06 June 2001 Sustainable Development
Books 1

1. Kök Hücre Alıcılarında Enfeksiyonlar

GÜZEL TUNÇCAN Ö., ŞENOL E.
in: Enfeksiyon Hastalıkları ve Mikrobiyolojisi Sistemlere Göre Enfeksiyonlar, Willke Topçu Ayşe, Söyletir Güner, Doğanay Mehmet, Editor, Nobel Tıp Kitabevleri, pp.661-668, 2017
Metrics

Publication

68

Publication (WoS)

39

Publication (Scopus)

41

Citation (WoS)

185

H-Index (WoS)

8

Citation (Scopus)

480

H-Index (Scopus)

9

Citation (Scholar)

50

H-Index (Scholar)

3

Citation (Sum Other)

2

Project

10

Thesis Advisory

6

Open Access

14
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 5: GOAL 5: GENDER EQUALITY
SDG 15: GOAL 15: LIFE ON HAND
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS
SDG 17: GOAL 17: PARTNERSHIPS FOR THE GOALS